Combined cardiorenal failure: A rapidly expanding clinical entity;Insuficiencia combinada cardiorrenal: Una entidad clínica emergente

Medicina Clinica

Volumn 121, Issue 18, 2003, Pages 710-717

  Caramelo, Carlos ^a,b   Gil, Paloma ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Adaptation; Cardiac insufficiency; Cardio renal insufficiency; Renal insufficiency; Survivors; Systemic arteriosclerosis

Indexed keywords

ARTERIOLOSCLEROSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FLUID BALANCE; FOLLOW UP; HEALTH CARE PERSONNEL; HEART FAILURE; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; PHYSICIAN ATTITUDE; PROGNOSIS; REVIEW; SPAIN; TRAINING;

EID: 0742318984     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13054617     Document Type: Review

References (50)

1. Survival, mortality and causes of death. Am J Kidney Dis 2003;41 (4Pt3):151-64.
2. Parfrey SM. Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence and risk. Am J Kidney Dis 2001;37:154-6.
3. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-convertirg-enzyme, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
4. Hansson L, Zanchetti A, Carruther SG, Dahlöf B, Elmfeldt D, Juluis S, et al. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1999;351:1755-63.
5. Mann DL. Mechanisms and models in heart failure: a combination approach. Circulation 1999;100:99-108.
6. Ruilope LM, Van Veldhuisen DJ, Ritz E, Luscher TF. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001;38:1782-7.
7. Pitt B, Segal R, Martínez FA, Meurers G, Cowley AJ, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-52.
8. Weber KT, Villarreal D. Aldosterone and antialdosterone therapy in congestive heart failure. Am J Cardiol 1993;71:3A-11A.
9. Cleland JG, Cohen Solar A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631-9.
10. Steimle AE, Stevenson LW, Chelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD, et al Sustained hemodynamic efficacy of therapy tailored to reduce filling pressure in survivors with advanced hear failure. Circulation 1997;96:1165-72.
11. Redfield MM. Heart failure - an epidemic of uncertain proportions. N Engl J Med 2002;347:1442-4.
12. Grupo de trabajo de la IC de la Sociedad Española de Medicina Interna. Insuficiencia cardíaca en los servicios de medicina interna (estudio Semi-IC). Med Clin (Barc) 2002;118:605-10.
13. Anguita Sánchez M, Vallés Elsúe F. ¿Quién debe tratar la insuficiencia cardíaca? Rev Esp Cardiol 2001;54:815-8.
14. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25.
15. Muntner P, He J, Hamm L, Loira X, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002;13:745-53.
16. Friedman PJ. Serum creatinine: an independent predictor of survival after stroke. J Intern Med 1991;229:175-9.
17. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002;62:997-1004.
18. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002;62:1402-7
19. 4 product and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001;12:2131-8.
20. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-36.
21. Ismail N, Badr KF. The kidney in congestive heart failure. En: Stibe WJ, editor. Grand rounds in nephrology St. Louis: Mosby, 1992; p. 65-75.
22. Mühlberg W, Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology 1999;45:243-53.
23. Guyton AC, Hall JE. Cardiac failure. En: textbook of medical physiology. 8th ed. WB Saunders, 1991; p. 245-54.
24. a ed. McGraw-Hill, 1999; p 377-95.
25. Starling EH. The Linacre lecture on the law of the heart. London: Longmans Green&Co., 1918.
26. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 1999;10(Suppl 12):258-65.
27. Page E, Machecourt J, Dechelette E, Wolf JE, Bourlard P, Denis B. Treatment of cardiac failure with refractory edema using extracorporeal ultrafiltration. Arch Mal Coeur Vaiss 1984;77:1040-5.
28. Weinfeld MS, Chertow GM, Warner Stevenson L. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999;138:285-90.
29. Tsuyuki RT, McKelvie RS, Arnold JM, Avezum A, Barretto AC, Carvalho AC, et al. Acute precipitans of congestive heart failure exacerbations. Arch Intern Med 2001;161:2337-42.
30. Weber KT. Heart-hitting tales of SALT and destruction J Lab Clin Med 2000;136:7-13.
31. Cockcroft DW, Gault MH. Prediction of creatinine clearance form serum creatinine: Nephron 1976;16:31-41.
32. Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002;13:798-805.
33. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-62.
34. Sharpe DN, Douglas JE, Coxon RJ, Long B. Low-dose captopril in chornic heart failure: acute hemodynamic effects and long-term treatment. Lancet 1980;2:1154-7.
35. Oster JR, Materson BJ. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme ihhibitors. Arch Intern Med 1992;152:704-10.
36. Cohn JN. The management of chronic heart failure. N Engl J Med 1996;335:490-8.
37. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002;347:1256-61.
38. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000;160:685-93.
39. Jolobe OMP. Evaluation of renal function in elderly heart failure patients with ACE inhibitors. Postgrad Med J 1999;75:275-7.
40. Caramelo C. Homeostasis de la presión arterial. En: Hernando L, editor. Nefrología clínica. p. 180-4.
41. Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensi-converting enzyme inhibitors. How much should we worry? Arch Intern Med 1998;158:26-32.
42. Burnier M, Brunner HR. Neurohormonal consequences of diuretics in different cardiovascular syndromes. Eur Heart J 1992;13(Suppl G):28-33.
43. Russo D, Memoli B, Andreucci VE. The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol 1992;38 (Suppl):69-73.
44. Levin ER, Gardner DG, Samson WK. Mechanism of disease: natriuretic peptides. N Engl J Med 1998;339:321-8.
45. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Pérez A, et al. The effect of spironolactone on morbidity and mortality of patients with severe cardiac failure. N Engl J Med 1999;341:707-17.
46. Duprez D, De Buyzere M, Rietzchel ER, Clement DL. Aldosterone and vascular damage. Curr Hypert Reports 2000;2:327-34.
47. Pitt B, Remme W, Zannad F, Neaton J, Martínez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
48. Reis SE, Holubkov R, Edmundowicz D, McNamara DM, Zell KA, Detre KM et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol 1997;30:733-8.
49. Philbin EF, Jenkins PL. Differences between patients with heart failure treated by cardiologists, internists, family physicians, and other physicians: analysis of a large, statewide database. Am Heart J 2000;139:491-6.
50. Rich MW, Beckham V, Wittenberg C, Leven CL, Freeland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.